跳至主要内容
临床试验/JPRN-UMIN000039653
JPRN-UMIN000039653已完成未知

The HGCSG1902 Study; An investigator-initiated, multicenter, prospective observational study on cases of dysgeusia caused by chemotherapy for gastroenterological cancer - HGCSG1902

Hokkaido Gastrointestinal Cancer Study Group0 个研究点目标入组 180 人开始时间: 2020年3月2日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients with serious complications (heart failure, liver failure, renal failure, active gastrointestinal ulcer, intestinal paralysis, etc.) 2.Patients with clinically significant mental or central nervous system disorders. 3.Patients with a history of head and neck radiation therapy. 4.Women who are pregnant or may become pregnant. Lactating woman. 5.Patients already taking zinc-containing preparations (including supplements) 6.Patients who are allergic to zinc-containing preparations. 7.Patients planning to finish chemotherapy within 12 weeks. 8.Patients whose physician predicts that it is difficult to continue chemotherapy for more than 12 weeks. 9.Participation in the clinical trial is determined as unsuitable.

研究者

相似试验